|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
59,420,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Generation Bio is a genetic medicines company providing durable, redosable treatments for potentially various of patients living with rare and prevalent diseases. Co.'s non-viral genetic medicine platform incorporates its DNA construct called closed-ended DNA; its cell-targeted lipid nanoparticle delivery system; and its capsid-free manufacturing process that uses its proprietary cell-free rapid enzymatic synthesis, to produce ceDNA. Using Co.'s platform, it is developing genetic medicines to provide targeted delivery of genetic payloads that include large and multiple genes to a range of cell types across a range of diseases.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
551,455 |
551,455 |
642,217 |
Total Buy Value |
$0 |
$778,895 |
$778,895 |
$1,265,385 |
Total People Bought |
0 |
4 |
4 |
4 |
Total Buy Transactions |
0 |
7 |
7 |
12 |
Total Shares Sold |
0 |
4,890 |
11,122 |
27,899 |
Total Sell Value |
$0 |
$7,922 |
$39,768 |
$125,583 |
Total People Sold |
0 |
2 |
2 |
2 |
Total Sell Transactions |
0 |
2 |
4 |
10 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mcdonough Geoff |
PRESIDENT AND CEO |
|
2024-04-15 |
4 |
D |
$3.70 |
$5,728 |
D/D |
(1,548) |
1,323,458 |
|
- |
|
Mcdonough Geoff |
PRESIDENT AND CEO |
|
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,274 |
1,325,006 |
|
- |
|
Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
|
2024-04-15 |
4 |
D |
$3.70 |
$3,641 |
D/D |
(984) |
52,622 |
|
- |
|
Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
|
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,347 |
53,114 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2024-04-15 |
4 |
D |
$3.70 |
$1,820 |
D/D |
(492) |
244,955 |
|
- |
|
Stanton Matthew |
CHIEF SCIENTIFIC OFFICER |
|
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,674 |
245,447 |
|
- |
|
Samayoa Phillip |
CHIEF STRATEGY OFFICER |
|
2024-04-15 |
4 |
D |
$3.70 |
$1,247 |
D/D |
(337) |
113,758 |
|
- |
|
Samayoa Phillip |
CHIEF STRATEGY OFFICER |
|
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,147 |
114,095 |
|
- |
|
Paone Antoinette |
CHIEF OPERATING OFFICER |
|
2024-04-15 |
4 |
D |
$3.70 |
$1,732 |
D/D |
(468) |
13,807 |
|
- |
|
Paone Antoinette |
CHIEF OPERATING OFFICER |
|
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,592 |
14,275 |
|
- |
|
Howze Yalonda |
CHIEF LEGAL OFFICER |
|
2024-04-15 |
4 |
D |
$3.70 |
$14,541 |
D/D |
(3,930) |
9,458 |
|
- |
|
Howze Yalonda |
CHIEF LEGAL OFFICER |
|
2024-04-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,388 |
13,388 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2024-01-29 |
4 |
D |
$1.90 |
$2,804 |
D/D |
(1,476) |
49,164 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2024-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,021 |
50,640 |
|
- |
|
Kerr Douglas |
CHIEF MEDICAL OFFICER |
|
2024-01-29 |
4 |
D |
$1.90 |
$2,804 |
D/D |
(1,476) |
385,628 |
|
- |
|
Kerr Douglas |
CHIEF MEDICAL OFFICER |
|
2024-01-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,021 |
387,104 |
|
- |
|
Samayoa Phillip |
CHIEF STRATEGY OFFICER |
|
2024-01-15 |
4 |
D |
$1.91 |
$5,768 |
D/D |
(3,020) |
112,948 |
|
- |
|
Samayoa Phillip |
CHIEF STRATEGY OFFICER |
|
2024-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,712 |
114,538 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2024-01-15 |
4 |
D |
$1.91 |
$9,353 |
D/D |
(4,897) |
45,619 |
|
- |
|
Zimmermann Tracy |
CHIEF DEVELOPMENT OFFICER |
|
2024-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,131 |
47,939 |
|
- |
|
Paone Antoinette |
CHIEF OPERATING OFFICER |
|
2024-01-15 |
4 |
D |
$1.91 |
$6,947 |
D/D |
(3,637) |
12,683 |
|
- |
|
Paone Antoinette |
CHIEF OPERATING OFFICER |
|
2024-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,492 |
14,890 |
|
- |
|
Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
|
2024-01-15 |
4 |
D |
$1.91 |
$10,463 |
D/D |
(5,478) |
50,259 |
|
- |
|
Norkunas Matthew |
CHIEF FINANCIAL OFFICER |
|
2024-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,805 |
50,840 |
|
- |
|
Kerr Douglas |
CHIEF MEDICAL OFFICER |
|
2024-01-15 |
4 |
D |
$1.91 |
$9,353 |
D/D |
(4,897) |
382,083 |
|
- |
|
293 Records found
|
|
Page 1 of 12 |
|
|